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Abstract 112 
Primary open-angle glaucoma (POAG), the most common optic neuropathy, is a heritable disease. 113 
Siblings of POAG cases have a ten-fold increase risk of developing the disease. Intraocular pressure 114 
(IOP) and optic nerve head characteristics are used clinically to predict POAG risk. We conducted a 115 
genome-wide association meta-analysis of IOP and optic disc parameters and validated our findings 116 
in multiple sets of POAG cases and controls. Using imputation to the 1000 genomes (1000G) 117 
reference set, we identified 9 new genomic regions associated with vertical cup disc ratio (VCDR) and 118 
1 new region associated with IOP. Additionally, we found 5 novel loci for optic nerve cup area and 6 119 
for disc area. Previously it was assumed that genetic variation influenced POAG either through IOP or 120 
via changes to the optic nerve head; here we present evidence that some genomic regions affect 121 
both IOP and the disc parameters. We characterized the effect of the novel loci through pathway 122 
analysis and found that pathways involved are not entirely distinct as assumed so far. Further, we 123 
identified a novel association between CDKN1A and POAG. Using a zebrafish model we show that 124 
six6b (associated with POAG and optic nerve head variation) alters the expression of cdkn1a. In 125 
summary, we have identified several novel genes influencing the major clinical risk predictors of 126 
POAG and showed that genetic variation in CDKN1A is important in POAG risk. 127 
 128 
 129 
 130 
 131 
 132 
 133 
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Introduction 134 
In primary open-angle glaucoma (POAG), loss of retinal ganglion cells and nerve fibers manifests itself 135 
clinically as optic nerve damage, which leads to visual field loss and, eventually in 15% of these with 136 
visual loss to visual impairment and blindness (1-3). The optic nerve damage is characterized by an 137 
increase in cup area, the central portion of the optic nerve head (or optic disc), and/or a decrease in 138 
rim area (the area of the disc occupied by the retinal nerve fiber axons). This damage can be 139 
quantified by the vertical cup-disc ratio (VCDR), comparing the vertical diameter of the cup with the 140 
vertical diameter of the total optic disc. The VCDR ranges from 0 to 1. In the clinical setting, optic 141 
nerve heads with a VCDR above 0.7 or an asymmetry between eyes above 0.2 are considered to be 142 
suspect for glaucoma. The interpretation of VCDR depends on the disc area, i.e. discs with larger area 143 
have on average a higher VCDR and the cut-off point between a normal and abnormal VCDR might be 144 
higher (4). 145 
Elevated intraocular pressure (IOP) is a well-recognized risk factor for POAG and current  therapies 146 
lower IOP by various mechanisms; eye pressure is considered to be normal between 8 and 21 mmHg, 147 
although many eyes with eye pressure in this range can exhibit glaucomatous optic nerve features. 148 
Analyses of first-degree relatives of POAG patients, have shown that the sib relative risk is 10.4 ± 2.5  149 
(5).Classic twin studies in POAG are lacking and there is no consensus on heritability for POAG, but 150 
work by Cuellar-Partida et al estimated the heritability of POAG based on genome-wide array data at 151 
0.42 ± 0.09(6). Several genome-wide association studies (GWAS) have identified new POAG genes by 152 
examining POAG directly or studying endophenotypes like VCDR and IOP(7-16). Several genes 153 
associated with VCDR and IOP - CDKN2B-AS1, SIX6 (VCDR); and CAV1/CAV2, TMCO1, ABCA1 and 154 
ARHGEF12 (IOP) - are associated with POAG. Notably, no genes have been genome-wide associated 155 
with both VCDR and IOP. Charlesworth et al. previously found a genetic correlation between VCDR 156 
and IOP (RhoG = 0.45, P = 0.0012), however, genes underlying this relationship have not yet been 157 
identified(17). 158 
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The aims of this study were to (1) identify new genes associated with the POAG endophenotypes IOP, 159 
VCDR, cup area, and disc area, and ultimately POAG, using the 1000 Genomes imputations reference 160 
panel, and (2) investigate the genetic overlap between the different endophenotypes. To accomplish 161 
these aims we performed a meta-analysis of GWAS of these four traits within the International 162 
Glaucoma Genetics Consortium (IGGC). 163 
164 
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Results 165 
Intraocular pressure 166 
We first conducted a meta-analysis of GWAS in the European cohorts, top hit variants were 167 
replicated in the Asians meta-analysis. Next, we performed a meta-analyses of the European and 168 
Asians cohorts. After removal of single nucleotide polymorphisms (SNPs) with minor allele frequency 169 
(MAF) < 0.01 and low imputation quality, approximately 8 million SNPs were included. Whilst the 170 
meta-analysis of individuals of European descent yielded no novel associations, combined meta-171 
analysis of individuals of European and Asian descent (n = 37,930, λ = 1.05; Supplementary Material, 172 
Figs S1a, S1b and S2b), yielded nine genomic regions reaching genome-wide significance, of which 173 
eight genomic regions were already known (Supplementary Material, Figs S1a, S1b, S2b, and Table 174 
S3)(9, 11, 13). The peak SNP in the new genomic region was rs55796939 on chromosome 11q25 near 175 
ADAMTS8 (Supplementary Material, Figs S3 and S4).The estimated heritability (h2) of IOP using the 176 
LD score regression method(18) and the summary statistics of European-only meta-analysis was 0.13. 177 
 178 
Vertical cup-disc ratio 179 
In the meta-analysis of individuals of European descent (n = 23,899, λ = 1.08), 21 genomic regions 180 
were genome-wide significant (Supplementary Material, Figs S5a, S6a and Table S4). Five genomic 181 
regions were novel (near to the genes RPE65 on chr. 1p31, F5 on chr. 1q23, PDZD2 on chr. 5p13.3, 182 
RREB1 on chr. 6p25, and DGKB on chr. 7p21.2) (Supplementary Material, Figs S7 and S8); the other 183 
genomic regions have been previously associated with VCDR or cup area, two highly correlated 184 
traits(19-21). Of the five novel genomic regions, RREB1 (p-value = 4.13 x 10-3) was nominally 185 
significant in the analysis of individuals of Asian descent (n= 8,373, λ = 1.01). In the combined analysis 186 
(n = 32,272, λ = 1.06), another four novel genomic regions, near to the genes VCAN on chr. 5q14.3, 187 
PSCA on chr. 8q24.2, ENO4 on chr. 10q25.3, and RBM23 on chr. 14q11.2 (Supplementary Material, 188 
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Figs S5b and S6b), were genome-wide significant leading to a total of nine (5+4) novel genomic 189 
regions associated with VCDR. Of these novel genomic regions, F5 has been associated with disc area 190 
previously(21). Disc area influences the VCDR(22), and therefore we corrected VCDR for disc area in a 191 
secondary analysis. After correction for disc area, the β (p-value) decreased from -0.007 (2.15 x 10-9) 192 
to -0.002 (5.60 x 10-2) in the subset with disc area available, suggesting that F5 acts primarily on disc 193 
area and secondary to VCDR through its relation to disc area. The calculated h2 of VCDR using the 194 
European -only meta-analysis was 0.31. 195 
 196 
Cup area 197 
The meta-analysis of individuals of European descent (n = 22,489, λ = 1.06) yielded 17 genome-wide 198 
significant regions of which 14 regions were already implicated for cup area or VCDR (Supplementary 199 
Material, Figs S9a, S10a and Table S5)(20, 21). There were three novel associations on chr. 1q42.11 200 
near CDC42BPA, chr. 8q21.11 near CRISPLD1, and on chr. 15q26.3 near FAM169B (Figs S11 and S12). 201 
CDC42BPA has previously been associated with disc area and the fact that the association with cup 202 
area adjusting for disc area is genome wide significant suggests an independent effect on cup area. In 203 
the combined analysis of European and Asian individuals (n = 29,828, λ = 1.06, Supplementary 204 
Material, Figs S9b and S10b) all loci except FAM169B and CRISPLD1 remained genome-wide 205 
significant, and there was one additional genome-wide significant SNPs at chr. 6p21.2 (CDKN1A) and 206 
one highly suggestive significant SNP at chr. 9q34.2 (ABO; previously associated to IOP). For cup area 207 
the estimated h2 was 0.27. 208 
 209 
Disc area 210 
The meta-analysis of individuals of European descent (n = 22,504, λ = 1.06) resulted in 13 genome-211 
wide significant regions, of which two were not previously associated with disc area: UGT8 on chr. 212 
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4q26 and CTNNA3 on chr. 10q22.2 (Supplementary Material, Figs S13a, S14a, S15, S16, and Table 213 
S6). These SNPs were not significant in the meta-analysis of individuals of Asian descent (n = 7,307, λ 214 
= 1.02). An additional four SNPs reached genome-wide significance in the combined meta-analysis (n 215 
= 29,811, λ = 1.07): PRDM16 on chr. 1p36.23-p33, GADD45A on chr. 1p31.2, VGLL4 on chr. 3p25.3, 216 
and ASB7 on chr. 15q26.3 (Supplementary Material, Figs S13b and S14b). The estimated h2 for disc 217 
area was 0.27. 218 
 219 
Characterization of the lead association signals 220 
In total, 82 SNPs were associated with one or more of the above endophenotypes. Functional 221 
characterization of the 82 SNPs was performed using a range of bioinformatics tools (see Methods). 222 
In total, 650 variants in linkage disequilibrium (LD) with the 82 lead SNPs (R2 >0.8) were examined for 223 
functional annotation. Overall, 61% (50/82) of the associated loci are in LD with variants located in 224 
regulatory regions according to the ENCODE data (e.g. DNase I hypersensitive sites, transcription 225 
factor binding sites and motifs; see Supplementary Material, Table S7). We investigated the 226 
expression levels of the identified candidate genes using the UniGene database(23). Of all reviewed 227 
genes, CDKN1A, PAX6 and DUSP1 showed the highest number of transcripts per million in the eye 228 
(Supplementary Material, Table S8). According to the Ocular Tissue database(24), CDKN1A is highly 229 
expressed in the optic nerve head, as well as DUSP1, which also shows high expression in the 230 
trabecular meshwork. Both genes were associated with optic nerve head parameters. PAX6 is highly 231 
expressed in the ciliary body and retina, in this study we found it associated with disc area. Other 232 
highly expressed genes in the optic nerve include EFEMP1 and ABI3BP, which are associated with cup 233 
area and disc area, respectively (Supplementary Material, Table S9). To evaluate whether associated 234 
genes are highly expressed in a particular tissue, we performed tissue enrichment analyses for each 235 
trait using suggestive SNPs (p-value < 1.00 x 10-05) in DEPICT(25). No FDR significant tissue enrichment 236 
was found for IOP, VCDR or disc area. However, for cup area we found an enrichment for 237 
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membranes, joints, stem cells and other related connective tissues. Similar results were found when 238 
suggestive SNPs associated with VCDR, cup and disc area (the optic nerve parameters) were analyzed 239 
together (Table S10). 240 
 241 
Gene-based test 242 
To identify new loci not found through per-SNP tests, we performed gene-based testing using 243 
VEGAS2. Reflecting the smaller number of tests, our gene-based significance threshold is Pgene-based < 244 
0.05/24,769 = 2.02 x 10-6 (24,769 genes tested). Using the gene-based test we found several novel 245 
loci (Supplementary Material, Table S11). C9 was significantly associated with IOP (p-value 1.61 x 10-246 
6); RARB (p-value 1.86 x 10-6) and HORMAD2-AS1 (p-value 1.04 x 10-6) were associated with VCDR. 247 
These genes were previously associated with disc area, so the novel associations with VCDR could 248 
possibly be driven by the influence of disc area on VCDR(21). In the cup area analysis, the genes 249 
LRP10 (p-value 1.20 x 10-6) and REM2 (p-value 1.55 x 10-6), and THSD4 (p-value 5.44 x 10 8) were 250 
significantly associated. The first two genes are located near to RBM23, which was significant in the 251 
per-SNP test. THSD4 is located near to KPNB1, which was associated with VCDR in our previous meta-252 
analysis(20). In the disc area analysis we found two genes that were significantly associated with disc 253 
area: ANKRA2 (p-value 8.42 x 10-7) and LOC149950 (p-value 3.87 x 10-7). 254 
 255 
Characterizing the overlap in biological pathways involved in glaucoma endophenotypes 256 
In total, 86 SNPs were associated with one or more of the above endophenotypes. The effect 257 
estimates and p-values of these SNPs for all four endophenotypes are shown in Table 1-3. ADAMTS8 258 
(IOP and VCDR, Table 1 and Table2b) and ABO (IOP and cup area, Table 1) were genome-wide 259 
significantly associated with two traits. Of note is that there were different variants involved in 260 
ADAMTS8: rs55796939 for IOP and rs4936099 for VCDR (r2=0.03 between these SNPs in 1000G 261 
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European samples). Figure 1 shows the overlap in associations across endophenotypes – we depict 262 
annotated genes for which at least one SNP was genome-wide significant in at least one trait. 263 
Overlap is defined as nominal significance or stronger for the second trait. The figure shows as 264 
expected a strong overlap in variants associated to disc area, cup area and VCDR. Further, overlap is 265 
noted in genes associated to IOP, cup area and VCDR. We next explored the genetic overlap between 266 
optic disc parameters and IOP using our GWAS results from the European-only meta-analyses, which 267 
comprised a larger sample size (n=22,489-29,578). As expected genetic correlation between optic 268 
disc parameters was high, VCDR and cup area showed the highest correlation (RhoG = 0.83, p-value < 269 
1.0 x 10 -308), followed by VCDR and disc area (RhoG = 0.62, p-value = 7.36 x 10-23). Genetic correlation 270 
between cup and disc area was 0.31 (p-value = 1.00 x 10-04). No significant genetic correlation was 271 
found between IOP and optic disc parameters, the highest correlation was between IOP and VCDR 272 
(RhoG = 0.06, p-value 0.3) (Table S12). 273 
To further characterize the overlap in biological functions, gene set enrichment of loci associated 274 
with IOP and optic disc parameters was performed using DEPICT(25). We first investigated enriched 275 
pathways or gene sets using only genome-wide associated SNPs. No significant pathways were found 276 
after FDR correction. However, pathways involved in metabolic processes such as “increased 277 
circulating leptin level”, “abnormal fat cell morphology” and “increased insulin sensitivity” were 278 
suggestive when we analyzed the list of SNPs associated with VCDR, cup area and disc area (FDR<0.2, 279 
see Supplementary Material, Table S13). We next searched for enriched pathways using suggestive 280 
SNPs (p-value <1.0 x 10-5). We further investigated potential overlap in pathways across the 281 
endophenotypes, and found 57 significant pathways when using VCDR, cup area and IOP variants; 282 
and 100 pathways when analysing suggestive VCDR, cup area and disc area variants. Note that in the 283 
first analysis we investigated pathways enriched when IOP genes are taken into account, while in the 284 
second one we analysed genes influencing the optic nerve head characteristics. Due to a high degree 285 
of redundancy between pathways, we clustered the significant pathways into meta-pathways, 286 
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resulting in 11 meta-pathways for VCDR, cup area and IOP (Figure 2a, Supplementary Material, 287 
Table S14); and 17 for VCDR, cup area, and disc area (Figure 2b, Supplementary Material, Table 288 
S15). Most of the gene sets found in both analyses highlighted pathways involved in cell 289 
differentiation, notch signaling, regulatory DNA binding and embryonic development, which reflects 290 
the pathways found when VCDR and CA variants are analyzed (Supplementary Material, Fig S17). 291 
Furthermore, we found “abnormal fat cell morphology” and “abnormal liver morphology” 292 
significantly enriched; a key gene in these pathways is ABCA1. When IOP genes are included the 293 
elongation factor, RNA Polymerase II (ELL2) protein complex” shows an enrichment. When disc area 294 
genes are included, pathways such as “blood vessel development”, “protein import into nucleus”, 295 
“Thrombospondin 1 (THBS1) and SMAD3 protein complex”, and “abnormal eye morphology” were 296 
significant. Key genes in the latter include: CDKN2B, FAT4, LRIG3, SIX6, COL8A1, SOX11, RND3, BOC, 297 
WNT2B and CYP26A1. 298 
 299 
From endophenotypes to primary open-angle glaucoma 300 
To evaluate the implications of our findings in the context of glaucoma, we examined the association 301 
between the genome-wide significant SNPs found in this study and 4 independent POAG studies (n= 302 
6,429 cases and 41,404 controls). In total, 75 independent (i.e. R2 < 0.8) SNPs associated with one or 303 
more of the endophenotypes were assessed in the case/control studies. Of these, 32 were nominal 304 
significantly associated with POAG (p-value <0.05; the chance that 32 SNPs of 75 SNPs have a p-value 305 
<0.05 is < 2.2 x 10-16), and 11 independent SNPs were Bonferroni significantly associated with POAG 306 
(p-value 0.05/75 = 6.67 x 10-4) (Table 4). Two out of the 11 Bonferroni significant SNPs, the 307 
rs2487048 in the ABCA1 gene and the 11:120357425 in the ARHGEF12 showed high heterogeneity 308 
(I2). To estimate the common effect size we performed a random effect meta-analysis. The odds ratio 309 
(OR) remained almost the same for both variants, although p-values were not significant after 310 
adjusting for multiple testing, which is in line with the heterogeneity observed. All other nine SNPs 311 
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surpassed the Bonferroni threshold for significance in both fixed and random-effect models. The 312 
association between CDKN1A and POAG is novel (OR = 1.14, p-value = 7.4 x 10-7). In our previous 313 
paper, the SNP rs6054374 near to BMP2 was already associated with POAG (OR = 0.92, p-value 3.74 x 314 
10-3), but the most significantly associated SNP in the current meta-analysis rs6107845 near to BMP2 315 
shows a slightly larger effect on POAG (OR = 0.89, p-value = 8.52 x 10-6). CDKN1A, the novel 316 
associated POAG candidate gene belongs to the cyclin dependent kinase inhibitor (CDKN) gene family 317 
as well as CDKN2A, CDKN2B/CDKN2B-AS1, which all lie in a well-known glaucoma associated locus on 318 
chr.9p21. 319 
 320 
Expression of cdkn1a after knockdown of six6b in zebrafish 321 
Previous studies have shown that the transcription factor SIX6 alters the expression of CDKN2A and 322 
CDKN2B (26, 27). All three genes (SIX6, CDKN2A and CDKN2B) are in loci associated with POAG, 323 
suggesting a possible functional link between these POAG-loci. Given that CDKN1A is part of the 324 
same gene family as CDKN2A and CDKN2B we tested whether SIX6 also regulates CDKN1A. To assess 325 
the potential for functional regulation of CDKN1A through SIX6, we first performed in silico analyses 326 
and observed that SIX6 binds to CDKN1A (core score = 0.812). Then we used a previously studied 327 
zebrafish model(27), in which we tested whether knockdown of six6b alters the expression of cdkn1a 328 
in vivo. Knockdown of six6b was achieved using morpholino technology(27). 85% of the knockdown 329 
embryos showed a small eye phenotype, reduced optic nerve thickness and an up-regulation of the 330 
expression levels of cdkn2a/cdkn2b, as observed in previous studies (n=220)(27, 28). In zebrafish, 331 
there is only one gene which is analogous to the human CDKN2A and CDKN2B and it is referred to in 332 
this paper as cdkn2a/cdkn2b. We evaluated the expression levels of cdkn1a in eyes of six6b deficient 333 
embryos by RT-qPCR. A 41-fold overexpression of cdkn1a in the eye of six6b knockdown embryos 334 
was found (p-value = 0.001) (Figure 3), showing that in vivo downregulation of six6b affects the 335 
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expression levels not only of cdkn2a/cdkn2b but also of cdkn1a, likely by binding to their sequence, 336 
repressing their expression. 337 
 338 
Discussion 339 
This meta-analysis within the IGGC identified a novel genomic region associated with IOP, nine 340 
genomic regions associated with VCDR, five with cup area, and six with disc area. Eleven genomic 341 
regions were associated with POAG. Of these regions, the association between CDKN1A and POAG is 342 
novel.  343 
We identify some specific loci that underlie the genetic correlation between IOP and VCDR described 344 
earlier(17). ADAMTS8 and ABO were genome-wide significant for both IOP and VCDR or cup area. 345 
Variants found close to ABO (rs8176672 for cup area and rs8176741 for IOP) are in LD (r2 >0.85) with 346 
rs12216891, which lies in an enhancer and promoter histone mark, suggesting a potential regulatory 347 
mechanism in that region. Furthermore, TRIOBP is genome-wide significant for cup area, and reached 348 
a p-value of 3.42 x 10-6 for IOP. Interestingly, TRIOBP is approximately 180 kb away from CARD10 349 
which is associated with disc area. There is a large overlap between VCDR/cup area and disc area. 350 
Since VCDR is related to disc area, it might be that the effect found for VCDR is due to the effect of 351 
disc area. Most of these overlapping genes are still Bonferroni significant in the cup area analysis in 352 
which we corrected for disc area. Only CDC7/TGFBR3 and F5 are genome-wide significant for VCDR as 353 
well as for disc area, but the effect is negligible after correction for disc area, suggesting that these 354 
two genes play primarily a role in disc area. 355 
When suggestive SNPs (p-value <1.0 x 10-5) for VCDR and cup area are analyzed together using 356 
DEPICT, we found an enrichment of pathways involved in cell differentiation, development, 357 
regulatory DNA binding and Notch signaling. Including disc area SNPs to the VCDR and cup area 358 
analysis reveals additional joint pathways: 1) eye and blood vessel development, 2) cancer, 3) protein 359 
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import into nucleus, and 4) thrombospondin 1 and SMAD3 complexes, related to the extracellular 360 
matrix. The extracellular matrix pathway has been previously implicated in optic nerve 361 
degeneration(20). ADAMTS8 , COL8A1 and the novel identified gene VCAN (versican) are involved in 362 
the metabolism and composition of the extracellular matrix. Interestingly, mutations in VCAN have 363 
been implicated in several ophthalmologic disorders(29).Of interest, known POAG genes also fit in 364 
the pathways identified in this study, for example  GAS7 and SIX6 play a role during development(27, 365 
30), TGFBR3 has been implicated in extracellular matrix regulation(31) and in cancer as well as 366 
GMDS(32).  367 
Common variants in CDKN2B and its antisense CDKN2B-AS1 have been robustly found associated 368 
with POAG. The gene CDKN1A, also known as p21, CIP-1 or WAF-1, belongs to the same family as 369 
CDKN2B and also encodes a cyclin-dependent kinase inhibitor. Upregulation of CDKN1A causes G1 370 
arrest and inhibits proliferation of the cell. Herein, for the first time, we provide genome-wide 371 
significant evidence for association of CDKN1A variants with cup area. Two prior small cohort studies 372 
suggested a possible role of CDKN1A in POAG. Tsai et al.(33) found an association between a codon 373 
31 polymorphism in CDKN1A and POAG in 58 patients and 59 controls from China (OR = 2.39 [1.14-374 
5.01]). Saglar et al. found no statistically significant association between the codon 31 polymorphism 375 
and POAG in 75 patients and 119 controls from Turkey (OR = 1.70, p-value = 0.25)(34). Our study 376 
provides strong evidence for the role of CDKN1A in POAG risk in a large sample consisting of 6,429 377 
cases and 41,404 controls and shows the first convincing evidence for association of CDKN1A and 378 
POAG in individuals of European descent. A potential functional interaction between POAG-loci (i.e. 379 
SIX6 and CDKN genes) has been shown previously (26, 27). We performed in vivo studies in 380 
embryonic zebrafish eye and found that knockdown of six6b upregulates both cdkn2a/cdkn2b and 381 
cdkn1a. The mechanism behind the genetic variation in SIX6, and the CDKN genes remains obscure. 382 
However, in a recent study, Skowronska-Krawczyk et al. showed that SIX6 regulates the expression of 383 
CDKN2A in the context of IOP elevation (26). More comprehensive studies at the individual tissue 384 
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level e.g. retinal ganglion cell layer or optic nerve should be performed to evaluate the consequences 385 
of the genetic variation associated with POAG; for example, if associated variants in SIX6 lead to up-386 
regulation of CDKN genes. 387 
Genetic variation in CDK inhibitor genes has been found associated with various diseases and traits. 388 
SNPs close to CDKN1A, for example, have been associated with electrocardiographic measures (35) 389 
and colorectal cancer(36). While the CDKN2A/CDKN2B and CDKN2B-AS1 locus has been found in 390 
GWAS of Type 2 Diabetes(37), fasting glucose(38), intracranial aneurysm(39), myocardia 391 
infraction(40), coronary heart disease(41) and various cancer, including basal cell carcinoma(42), 392 
breast(43) and prostate(44) cancer, and glioma(45). Interestingly, the same allele in CDKN2B that 393 
decrease risk of POAG, was found associated with increased risk of glioma. The functional 394 
significance of the genetic variation in the CDK genes remains to be determined, possible mechanism 395 
in POAG might be related with the disruption of a delicate balance between proliferation and 396 
apoptosis.  397 
It has been suggested that p53 plays a role in POAG, especially in POAG with paracentral visual field 398 
loss(46). Intriguingly, p53 has been also related to the CDK-inhibitors and to four of the new genes 399 
pointed out by this study (GADD45A, PDZD2, RREB1 and PSCA). GADD45A is involved in growth arrest 400 
through p53-dependent and independent mechanisms(47, 48) and can interact via CDKN1A(49). 401 
PDZD2 is a tumor suppressor gene, reported to activate p53 by transcriptional regulation (50). RREB1 402 
has an effect on p53 by binding to its promotor and transactivates its expression(51). While PSCA 403 
expression correlates with the expression of p53 in choriocarcinoma, suggesting a role of PSCA in cell 404 
growth through p53-related pathways(52). Other genes play a role in apoptosis or cell growth via 405 
other mechanisms than p53: VGLL4 inhibits Bax- and TNFa-induced apoptosis(53) and DGKB is a 406 
regulator of diacylglycerol, which is important for cell growth and differentiation. UGT8 plays a role in 407 
the biosynthesis of the sphingolipids of myelin membranes of the central and peripheral nervous 408 
system; sphingolipids are also implicated in apoptosis(54). 409 
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Another interesting novel gene is RPE65 (retinal pigment epithelium -specific protein 65kDa). This 410 
gene has been associated with retinitis pigmentosa (RP) (55, 56) and Leber congenital amaurosis type 411 
2 (LCA2)(57). As the name implies, the encoded protein is located in the retinal pigment 412 
epithelium(58). Both diseases (RP and LCA2) are not characterized by an excavation of the optic 413 
nerve head. However, we have checked several online databases for expression in different tissues. 414 
In the eye, it is also highly expressed in the optic nerve head (S8 and S9 Tables) suggesting that this 415 
gene could be involved in other ocular processes. Little expression is found in the brain, with no 416 
expression in other tissues or organs in the body. Future studies are necessary to confirm our finding. 417 
Of the genes identified by gene-based testing, C9 (complement component 9) is especially 418 
interesting. Its protein is part of the membrane attack complex (MAC), together with the proteins 419 
C5b, C6, C7, and C8. This complex activates several steps that lead to cell death, and cells protect 420 
themselves by removing the complex through endocytosis. Caveolin is one of the proteins involved in 421 
endocytosis and the CAV1/CAV2 genes are associated with IOP and POAG. It has been shown that 422 
inhibition of caveolin-1 inhibits the endocytosis of MAC(59). 423 
To our best knowledge, this meta-analysis is the largest study of IOP and optic nerve head 424 
parameters to date, using well-characterized datasets from populations world-wide. A limitation of 425 
our study is the lack of an available dataset for replication of the novel associations detected by 426 
combined European and Asian ancestry samples. However, the heterogeneity of these novel genomic 427 
regions is generally low in the meta-analysis. For VCDR, cup area, and disc area we have identified 428 
novel SNPs in the analysis of individuals with European ancestry. Of the nine novel associations found 429 
in these populations (RPE65, PDZD2, RREB1, DGKB for VCDR; CDC42BPA, CRISPLD1 and FAM169B for 430 
cup area; and CTNNA3 and UGT8 for disc area), only RREB1 was nominally significant in the 431 
individuals with Asian ancestry. Five of the seven non-significant SNPs in the individuals with Asian 432 
ancestry had an effect estimate in the same direction. As the analysis in individuals with Asian 433 
ancestry contains a smaller number of individuals, this could be due to lack of power.  434 
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We have identified 21 genetic variants associated with POAG endophenotypes: IOP, VCDR, cup area, 435 
and disc area. The effect estimates of single SNP associations are small. We expected small effects of 436 
many SNPs, since glaucoma endophenotypes are highly polygenic traits(60). Although individual SNP 437 
effects are small, the joint effect of the various genetic variants could yield a clinical relevant 438 
parameter. These association results do not imply that the variants described here have a causal 439 
effect. Fine-mapping and functional studies are required to identify the causal variants tagged by our 440 
findings and the exact molecular mechanisms involved in POAG. Although the overlap between IOP-441 
loci and the optic disc parameters-loci is not large , this is the first study showing a genome-wide 442 
significant evidence of the genetic correlation between IOP and VCDR; we expect that larger sample 443 
sizes and improved imputation accuracy may help to find more of the loci underlying the genetic 444 
correlation between these two endophenotypes. Of the novel associations, CDKN1A is strongly 445 
associated with POAG, This finding is in line with other studies(26), pointing to the CDK-inhibitor 446 
genes as key players in the development of POAG. The p53 pathway has been implicated in POAG 447 
and interact in different cellular contexts with four of the new genes pointed out by this study 448 
(GADD45A, PDZD2, RREB1 and PSCA). Functional studies need to be performed to assess the role of 449 
p53 and CDK-inhibitors in the pathophysiology of POAG. A more comprehensive study of these 450 
mechanisms may inform the development of new therapies for POAG. 451 
452 
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Materials and methods 453 
Study design 454 
We performed a meta-analysis on directly genotyped and imputed SNPs to the 1000 Genomes 455 
reference panel. We analyzed four outcomes: IOP, VCDR, cup area, and disc area; the same approach 456 
was used for all four outcomes. In the first stage, we conducted a meta-analysis of GWAS including 457 
22,489-29,578 individuals of European ancestry. Subsequently, we evaluated the genome-wide 458 
significant SNPs from the first stage in a meta-analysis of GWAS including 7,307-8,373 individuals of  459 
Asian ancestry. Finally, we performed a mega/meta-analysis of GWAS  from all individual studies 460 
including individuals of European and Asian ancestry. We subsequently tested the effect of all 461 
genome-wide significant SNPs on POAG in four independent case-control studies (n = 6,429/41,404). 462 
These cases are not part of our primary meta-analyses which focused on quantitative traits in the 463 
general population (IOP, VCDR, cup area and disc area). Three of the case-control studies were of 464 
European ancestry(7, 61, 62) and one of Asian ancestry(63). 465 
 466 
Subjects, phenotyping and genotyping 467 
All 19 studies included in this meta-analysis are part of the IGGC (S1a Table).Details for each 468 
individual study can be found in Supplementary Material and Tables S1b, S1c and S2. The 469 
ophthalmological examinations included measurements of IOP and optic nerve head assessment. All 470 
19 studies contributed to the IOP mega/meta-analysis, 18 to the VCDR and 16 to the cup area and 471 
disc area mega/meta-analysis .Validation of mega/meta-analysis results was performed in four 472 
independent POAG case-control studies. Studies performed genomic imputation using 1000 473 
Genomes phase 1 reference samples . Study-specific quality control can be found in the 474 
Supplementary Material. All studies were performed with the approval of their local medical ethics 475 
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committee, and written informed consent was obtained from all participants in accordance with the 476 
Declaration of Helsinki. 477 
 478 
Statistical analysis 479 
In the IOP analysis, individuals who underwent IOP-lowering laser or surgery were removed from the 480 
analysis; in individuals receiving IOP-lowering medication, the IOP value was multiplied by 1.3 to 481 
estimate a pre-medication IOP value(64). The mean IOP, VCDR, cup area, and disc area of both eyes 482 
was used for the analyses. SNPs with MAF < 0.01 and imputation quality scores <0.3 (proper-info of 483 
IMPUTE) or R2<0.3 (MACH) were removed from the analyses. Each individual study performed a 484 
linear regression between each endophenotype (IOP, VCDR, cup area, and disc area) and the SNPs, 485 
under the assumption of an additive model for the effect of the risk allele. Analyses were adjusted 486 
for age, sex and the first five principal components (for population-based studies) or family structure 487 
(for family-based studies). 488 
We performed an inverse variance weighted fixed-effect meta-analysis with METAL software(65). P 489 
values for heterogeneity were calculated by using the Cochran’s Q-test for heterogeneity. SNPs with 490 
a p-value for heterogeneity <0.001 were removed from the results, as well as SNPs only present in 491 
three studies. We used the ‘genomic control’ option in METAL to correct the standard error of each 492 
individual study for estimated genomic inflation. To evaluate if our results exhibit signs of population 493 
stratification we estimated the intercept using the LD score regression method(18) in the European-494 
only meta-analyses. The intercept, which estimates inflation after removing polygenic signals, was: 495 
1.0142 for IOP, 1.0199 for VCDR, 1.0074 for cup area and 1.0167 for disc area (Table S16).  496 
In the meta-analyses of individuals with European ancestry, a p-value <5.0 x 10-8 (the genome-wide 497 
threshold of association) was considered significant. In the second stage, these genome-wide 498 
significant SNPs were validated in individuals with Asian ancestry, and in this look-up a p value <0.05 499 
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was considered significant. Finally, in the mega/meta-analysis of individuals with European and Asian 500 
ancestry a p-value of <5.0 x 10-8 was considered significant. In total, we identified 75 independent 501 
SNPs across different genomic regions for all the traits together. Therefore, the significance level 502 
after Bonferroni correction in the meta-analysis of POAG cohorts  was = 6.67 x 10-4 (0.05 / 75 503 
independent SNPs). To estimate the common effect size of the top SNPs associated with IOP, optic 504 
disc parameters and their effect in the look-up in the POAG cohorts a random-effect meta-analysis 505 
was performed using plink(66) http://pngu.mgh.harvard.edu/purcell/plink/ parameter --meta-506 
analysis. Manhattan, regional and forest plots were made using R(67) and LocusZoom(68). 507 
Genetic correlation between optic disc parameters (VCDR, cup and disc area) and IOP was estimated 508 
using the LD score regression method(18, 69). GWAS summary statistics from the Europeans-only 509 
meta-analyses were used to calculate the genetic overlap. To restrict the analyses to well imputed 510 
SNPs, we included only SNPs with MAF > 0.01 that were present in HapMap3. GWAS data were 511 
harmonized using the “munge_sumstats.py” function. For analyses we used the pre-computed LD 512 
scores for Europeans “eur_w_ld_ch” available at https://github.com/bulik/ldsc/wiki. The ldsc.py 513 
function (with all default settings) was used to calculate the genetic correlation between traits. In 514 
addition, we calculated the heritability (h2) estimates from the GWAS meta-analysis using the same 515 
function. 516 
Gene-based test using VEGAS 517 
A gene-based test was performed using the VEGAS2 software(70), with a 50kb gene boundary. We 518 
used the parameter ‘-top 100’ (default) to perform gene-based tests. This parameter considers 519 
association test statistics of all variants mapped to a gene to compute gene-based test statistics. The 520 
1000 Genomes European and Asian populations were used as a reference to calculate LD for 521 
European and Asian ancestry data respectively. After calculation of gene-based test statistics for 522 
Asian and European ancestry populations separately, meta-analyses were conducted using Fisher’s 523 
method for combining p-values. 524 
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Functional characterization, expression data, zebrafish and gene-set enrichment 525 
We investigated for evidence of regulatory functions of associated loci HaploReg version 2(71) and 526 
Regulomedb version 1.1(72). We investigated the expression of the associated genes using NCBI’s 527 
UniGene(23) and The Ocular Tissue Database(24). We also investigated the expression of cdkn1a in a 528 
six6b knockdown zebrafish and used DEPICT to investigate gene-set enrichment. More information 529 
about these analyses can be found in the Supplementary Material. 530 
Data access  531 
Access to the summary association statistics for IOP and optic disc parameters is available at 532 
http://getfiles.qimr.edu.au/puyaGharahkhani/1000G_imputed_IGGC_eye_quantitative_traits/ 533 
534 
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Legends to Figures 
Figure 1. Overlap between the genes associated with one or more endophenotypes. Genes 
with a genome-wide significant association for at least one trait are shown. These genes are 
counted as overlapping genes if they are Bonferroni significantly associated with the other 
trait(s). Chr 11p11.2 (see intraocular pressure circle) means a region on chromosome 
11p11.2 that is associated with IOP and has many genes in it; the likely causative gene in this 
region is not identified yet. Genes in bold are genes associated with primary open-angle 
glaucoma (POAG) in our meta-analysis of four case-control studies.*Genes associated with 
familial forms of POAG (e.g. MYOC and OPTN) or found in case-control association studies 
which did not show an association with the endophenotypes explored in this study.  
 
Figure 2. Pathways significantly enriched for: A) Loci associated with the vertical cup-disc ratio, 
cup area and intraocular pressure (p-value <7.0 x 10-6 in the GWAS). In total 11 meta-
pathways were identified after clustering the 57 pathways identified by DEPICT. B) Loci 
associated with vertical cup-disc ratio, cup area and disc area (p-value <1.0 x 10-5). In total 
17 meta-pathways were identified after clustering the 100 pathways identified by DEPICT. In 
both figures, meta-pathways are represented by nodes coloured according to statistical 
significance, and edges are scaled according to the correlation between meta-pathways. 
*The pathway “Abnormal eye morphology” clustered with the meta-pathway “Chordate 
embryonic development”. ELL2=Elongation Factor, RNA Polymerase II, DVL3= Dishevelled 
Segment Polarity Protein 3, THBS1=Thrombospondin 1, RFX2= Regulatory Factor X, 2. 
MDFI=MyoD Family Inhibitor.  
 
Figure 3. cdkn1a mRNA expression change 
Overexpression of cdkn1a and cdkn2a/cdkn2b in response to six6b depletion is shown. All 
samples expression were normalized to the control gene sdha. Relative expression was 
calculated by setting the wild-type expression level at 1. Values represent mean ± standard 
error of the mean. *P<0.05; **P<0.005. 
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Table 1. Single nucleotide polymorphisms (SNPs) that are genome-wide significantly associated with IOP and show and association with vertical cup-disc ratio.  
For these SNPs, the associations with the other traits are also included. SNPs that are Bonferroni significantly associated with other traits are shown in bold (p-value < 5.37 x 10-4; 
0.05/93). In the first rows, the SNPs genome-wide significantly associated with intraocular pressure (IOP) are shown. Next, the SNPs associated with IOP, vertical cup-disc ratio 
(VCDR), and cup area are shown. Nearest gene, reference NCBI build37; A1, reference allele; A2, other allele; β, effect size on the endophenotype (IOP, VCDR, cup area or disc area) 
based on allele A1; SE, standard error of the effect size; i, insertion; d, deletion; r, reference. *This locus was not considered as new because the signal came from only one INDEL 
(8:78380944). *Genome-wide associated in the European-only meta-analysis 
   IOP VCDR Cup area Disc area 
SNP Nearest gene A1/A2 β SE P β SE P β SE P Β SE P 
rs10918274 TMCO1 t/c 0.26 0.04 5.64E-12 0.005 0.002 8.38E-03 0.010 0.003 2.47E-03 0.000 0.006 9.49E-01 
rs7635832 FNDC3B g/t -0.22 0.03 6.61E-13 -0.001 0.001 3.35E-01 -0.004 0.003 1.27E-01 0.002 0.005 7.08E-01 
rs10281637 CAV1/CAV2 c/t 0.20 0.03 3.96E-13 0.004 0.001 5.28E-03 0.006 0.003 1.23E-02 -0.002 0.005 6.01E-01 
8:78380944* PKIA i/r 1.00 0.17 7.54E-09 0.000 0.010 9.74E-01 -0.018 0.017 3.00E-01 0.018 0.031 5.61E-01 
rs7815043* PKIA c/t -0.10 0.03 4.41E-05 -0.001 0.001 3.13E-01 -0.001 0.002 8.32E-01 -0.002 0.004 5.66E-01 
rs7944735 Many genes c/g 0.19 0.03 6.00E-11 0.001 0.001 4.37E-01 0.006 0.003 3.33E-02 0.000 0.005 9.68E-01 
11:120357425 ARHGEF12 d/r 0.18 0.03 2.02E-09 0.001 0.001 6.12E-01 0.001 0.003 6.45E-01 0.001 0.005 8.38E-01 
rs12794618 ARHGEF12 c/t 0.17 0.03 7.86E-09 0.001 0.001 4.14E-01 0.002 0.003 4.84E-01 0.004 0.005 4.53E-01 
rs55796939 ADAMTS8 t/c 0.36 0.06 2.31E-08 0.003 0.003 3.61E-01 0.006 0.006 3.19E-01 -0.003 0.010 7.95E-01 
               
rs2472496 ABCA1 g/a 0.17 0.02 1.93E-13 0.004 0.001 6.83E-05 0.010 0.002 9.63E-07 0.003 0.004 4.75E-01 
rs8176741 ABO a/g 0.24 0.04 3.47E-10 0.007 0.002 4.51E-05 0.019 0.003 7.12E-08 0.004 0.006 5.42E-01 
rs9913911 GAS7 g/a -0.17 0.02 7.01E-12 -0.006 0.001 1.84E-07 -0.008 0.002 2.48E-04 -0.001 0.004 8.41E-01 
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Table 2a. Single nucleotide polymorphisms (SNPs) that are genome-wide significantly associated with at least one of the optic disc parameters. 
   IOP VCDR   Cup area Disc area 
SNP Nearest 
gene 
A1/A2 β SE P β SE P β SE P Β SE P 
rs6804624 COL8A1 c/t -0.01 0.03 6.54E-01 0.008 0.001 8.63E-12 0.013 0.002 1.99E-08 0.020 0.004 9.67E-07 
rs7916697 ATOH7 a/g 0.01 0.03 7.43E-01 -0.018 0.001 2.46E-45 -0.017 0.002 1.32E-12 -0.094 0.004 1.34E-102 
10:96008348 PLCE1 d/r 0.01 0.03 5.73E-01 0.007 0.001 4.57E-08 0.013 0.002 1.72E-08 0.015 0.004 2.22E-04 
rs324780 TMTC2 g/a 0.03 0.02 2.79E-01 -0.011 0.001 7.16E-23 -0.016 0.002 1.57E-13 -0.029 0.004 8.58E-13 
rs4299136 ASB7 c/g -0.03 0.03 4.22E-01 0.010 0.002 2.68E-12 0.018 0.003 4.09E-10 0.024 0.005 4.02E-06 
16:51461915 SALL1 r/i 0.02 0.03 4.34E-01 0.010 0.001 2.62E-13 0.013 0.003 6.78E-07 0.032 0.005 2.38E-12 
rs4784295 SALL1 c/g 0.02 0.03 5.63E-01 0.009 0.001 3.93E-13 0.013 0.003 1.63E-07 0.031 0.005 1.12E-11 
rs5752773 CHEK2 g/c 0.01 0.03 6.91E-01 -0.012 0.001 1.49E-20 -0.024 0.003 4.12E-21 -0.024 0.005 1.48E-07 
rs2092172 CARD10 a/g 0.00 0.03 8.86E-01 0.009 0.001 3.08E-12 0.011 0.003 3.34E-05 0.032 0.005 1.44E-11 
rs7717697 VCAN c/t 0.01 0.02 7.21E-01 -0.007 0.001 6.66E-09 -0.009 0.002 1.19E-05 -0.018 0.004 4.84E-06 
rs1681739 ENO4 t/c 0.03 0.02 2.23E-01 0.006 0.001 2.44E-08 0.011 0.002 3.70E-07 0.019 0.004 1.85E-06 
rs60779155 ASB7 a/g -0.02 0.04 6.61E-01 0.010 0.002 3.76E-10 0.019 0.003 3.75E-09 0.030 0.006 8.26E-08 
rs1830890 PLCE1 g/a 0.01 0.02 8.14E-01 0.006 0.001 3.02E-08 0.012 0.002 1.06E-07 0.013 0.004 5.51E-04 
rs482507 TMTC2 c/t 0.02 0.02 3.48E-01 -0.011 0.001 2.19E-19 -0.017 0.002 2.56E-14 -0.030 0.004 4.49E-13 
rs4436712 SIX6 t/g -0.04 0.02 1.47E-01 0.009 0.001 5.48E-14 0.025 0.002 1.50E-29 -0.018 0.004 6.59E-06 
rs738722 CHEK2 t/c 0.02 0.03 3.57E-01 -0.012 0.001 4.94E-20 -0.024 0.003 7.81E-22 -0.021 0.005 2.63E-06 
rs2684249 HSF2 c/t 0.03 0.02 2.08E-01 -0.006 0.001 1.64E-07 -0.012 0.002 3.04E-08 -0.015 0.004 1.49E-04 
rs34222435 ASB7 t/c -0.03 0.03 3.86E-01 0.010 0.002 3.07E-12 0.019 0.003 1.07E-10 0.025 0.005 2.98E-06 
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   IOP VCDR Cup area Disc area 
SNP Nearest 
 
A1/A2 β SE P β SE P β SE P Β SE P 
rs7916410 ATOH7 t/c 0.00 0.03 9.76E-01 -0.018 0.001 1.14E-45 -0.017 0.002 6.11E-12 -0.097 0.004 7.06E-109 
rs442376 TMTC2 c/t -0.03 0.03 3.09E-01 0.011 0.001 1.50E-17 0.017 0.002 3.18E-12 0.032 0.004 4.92E-14 
rs1345467 SALL1 g/a 0.01 0.03 6.53E-01 0.009 0.001 4.96E-12 0.012 0.003 1.07E-06 0.032 0.005 6.41E-13 
rs5762752 CHEK2 c/g 0.01 0.03 6.61E-01 -0.011 0.001 4.83E-18 -0.021 0.002 6.72E-19 -0.023 0.004 2.26E-08 
rs11129176 RARB a/g 0.02 0.03 4.17E-01 0.005 0.001 3.17E-05 0.010 0.002 1.01E-05 0.023 0.004 3.40E-08 
rs1997404 COL8A1 g/t -0.03 0.03 3.24E-01 0.008 0.001 2.39E-11 0.013 0.002 7.71E-08 0.024 0.004 1.90E-08 
rs34935520 SIX6 g/a -0.04 0.02 1.13E-01 0.009 0.001 7.95E-14 0.025 0.002 6.96E-29 -0.023 0.004 7.61E-08 
For these SNPs, the associations with the other traits are also included. Here the SNPs genome-wide significantly associated with at least one of the optic disc parameters and  that 
are Bonferroni significantly associated with the other disc parameters are shown in bold (p-value < 5.37 x 10-4; 0.05/93).Nearest gene, reference NCBI build37; A1, reference allele; 
A2, other allele; β, effect size on the effect size on the endophenotype (IOP, VCDR, cup area or disc area) based on allele A1; SE, standard error of the effect size; i, insertion; d, 
deletion; r, reference. 
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Table2b. Single nucleotide polymorphisms (SNPs) that are genome-wide significantly associated with vertical cup-disc ratio or with cup area  
   IOP VCDR Cup area Disc area 
SNP Nearest gene A1/A
 
β SE P β SE P β SE P Β SE P 
rs1925953 RPE65* t/a -0.02 0.02 3.26E-01 0.006 0.001 1.55E-07 0.010 0.002 1.50E-05 0.006 0.004 1.08E-01 
rs72759609 PDZD2 c/t -0.04 0.05 3.50E-01 -0.012 0.002 7.10E-09 -0.020 0.004 1.98E-06 -0.021 0.008 5.62E-03 
rs11450334
6 
DUSP1 t/c -0.12 0.08 1.27E-01 -0.021 0.004 1.31E-08 -0.035 0.007 2.90E-07 -0.035 0.013 5.83E-03 
rs4960295 RREB1 a/g 0.02 0.02 4.75E-01 0.007 0.001 2.49E-10 0.009 0.002 3.73E-05 0.012 0.004 3.29E-03 
rs10274998 DGKB t/c 0.02 0.03 4.38E-01 0.008 0.001 4.68E-08 0.012 0.003 8.08E-06 0.011 0.005 2.65E-02 
rs2157719 CDKN2B-AS1 c/t -0.04 0.02 9.81E-02 -0.013 0.001 3.75E-35 -0.024 0.002 3.31E-28 -0.008 0.004 3.03E-02 
rs3891783 PLCE1 g/c 0.04 0.02 1.01E-01 0.007 0.001 1.06E-10 0.011 0.002 3.28E-07 0.012 0.004 1.52E-03 
rs1346 SSSCA1 t/a -0.05 0.03 1.20E-01 -0.013 0.002 7.51E-18 -0.019 0.003 9.31E-11 -0.016 0.005 2.10E-03 
rs4936099 ADAMTS8 c/a -0.03 0.03 2.38E-01 -0.007 0.001 6.70E-09 -0.013 0.002 4.96E-08 -0.006 0.004 1.72E-01 
13:3662990
5 
DCLK1 d/r -0.02 0.03 5.70E-01 0.007 0.001 2.98E-08 0.018 0.002 2.20E-14 -0.005 0.004 2.36E-01 
rs7323428 DCLK1 t/g -0.02 0.03 4.13E-01 0.007 0.001 1.86E-08 0.019 0.002 1.67E-15 -0.005 0.004 2.23E-01 
rs8015152 SIX6 t/c -0.06 0.02 2.27E-02 0.010 0.001 2.86E-18 0.024 0.002 8.15E-26 -0.011 0.004 6.18E-03 
rs6107845 BMP2 a/g 0.03 0.02 2.80E-01 -0.009 0.001 3.44E-17 -0.017 0.002 2.90E-15 -0.004 0.004 3.27E-01 
rs6764184 FLNB t/g 0.05 0.03 5.03E-02 0.007 0.001 1.89E-08 0.015 0.002 1.30E-10 0.010 0.004 1.92E-02 
rs7311936 FAM101A c/g -0.03 0.02 1.69E-01 -0.006 0.001 2.48E-09 -0.013 0.002 4.52E-09 0.003 0.004 5.14E-01 
14:2338879
3 
RBM23 r/d 0.02 0.03 3.99E-01 0.007 0.001 2.56E-08 0.013 0.003 2.01E-07 0.009 0.005 4.29E-02 
rs3794453 RBM23 a/t 0.01 0.02 7.22E-01 0.007 0.001 7.25E-08 0.011 0.002 2.88E-07 0.009 0.004 3.11E-02 
rs2252865 RERE t/c 0.05 0.03 4.11E-02 0.005 0.001 2.66E-05 0.014 0.002 1.33E-09 0.003 0.004 5.08E-01 
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   IOP VCDR Cup area Disc area 
SNP Nearest gene A1/A
 
β SE P β SE P β SE P Β SE P 
rs13016883 TRIB2 c/g 0.01 0.03 5.64E-01 0.006 0.001 3.44E-06 0.016 0.002 1.83E-11 0.001 0.004 8.30E-01 
rs35084382 DUSP1 c/t -0.10 0.07 1.32E-01 -0.018 0.003 2.05E-08 -0.033 0.006 2.17E-08 -0.031 0.011 5.51E-03 
rs11759831
0 
CRISPLD1* t/g -0.05 0.05 3.10E-01 0.009 0.002 1.07E-04 0.021 0.004 1.66E-06 0.022 0.008 5.47E-03 
rs1360589 CDKN2B-AS1 c/t -0.04 0.02 8.42E-02 -0.013 0.001 1.43E-34 -0.024 0.002 2.90E-28 -0.008 0.004 4.45E-02 
rs11613189 FAM101A t/c -0.03 0.03 2.27E-01 -0.005 0.001 6.04E-06 -0.016 0.002 2.01E-12 0.002 0.004 6.42E-01 
rs2251069 DDHD1 c/t 0.01 0.02 7.29E-01 -0.006 0.001 7.41E-08 -0.013 0.002 1.20E-09 0.001 0.004 7.11E-01 
rs6598351 FAM169B* t/c -0.02 0.03 5.26E-01 0.006 0.001 2.80E-05 0.012 0.003 1.77E-05 -0.004 0.005 3.90E-01 
rs11646917 SALL1 t/g -0.01 0.03 6.65E-01 -0.009 0.001 4.83E-10 -0.015 0.003 4.76E-09 -0.015 0.005 1.30E-03 
rs11867840 BCAS3 g/a 0.04 0.03 1.04E-01 -0.006 0.001 4.86E-06 -0.018 0.002 2.35E-13 0.011 0.004 1.00E-02 
rs6054375 BMP2 t/g 0.03 0.03 2.45E-01 -0.010 0.001 6.92E-15 -0.018 0.002 1.83E-15 -0.003 0.004 4.74E-01 
rs3791679 EFEMP1/PNPT
1 
g/a 0.04 0.03 1.72E-01 -0.005 0.001 1.17E-04 -0.013 0.002 4.92E-08 0.003 0.004 5.14E-01 
rs12494328 FLNB a/g 0.04 0.03 1.52E-01 0.006 0.001 1.56E-06 0.016 0.002 6.03E-11 0.009 0.004 4.50E-02 
6:36592986 CDKN1A d/r -0.02 0.03 5.32E-01 0.006 0.001 1.92E-05 0.015 0.003 1.12E-08 -0.006 0.005 2.09E-01 
rs72852338 CDKN1A c/a -0.02 0.03 5.46E-01 0.006 0.001 3.29E-05 0.014 0.003 3.17E-08 -0.005 0.005 2.97E-01 
rs1074407 TRIOBP t/a 0.11 0.02 4.00E-06 0.006 0.001 3.32E-07 0.012 0.002 1.90E-08 0.008 0.004 3.92E-02 
For these SNPs, the associations with the other traits are also included. Here the SNPs genome-wide significantly associated with vertical cup-disc ratio or cup area and that are 
Bonferroni significantly associated with VCDR or cup area are shown in bold (p-value < 5.37 x 10-4; 0.05/93).Nearest gene, reference NCBI build37; A1, reference allele; A2, other 
allele; β, effect size on effect size on the endophenotype (IOP, VCDR, cup area or disc area) based on allele A1; SE, standard error of the effect size; i, insertion; d, deletion; r, 
reference.*Genome-wide associated in the European-only meta-analysis 
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Table2c. Single nucleotide polymorphisms (SNPs) that are genome-wide significantly associated with vertical cup-disc ratio or with disc area 
   IOP VCDR Cup area Disc area 
SNP Nearest gene A1/A
2 
β SE P β SE P β SE P Β SE P 
rs1192414 CDC7/TGFBR
3 
a/g 0.06 0.03 5.66E-02 0.014 0.001 1.78E-23 0.007 0.003 1.12E-02 0.087 0.005 7.44E-71 
rs10753787 F5 t/c -0.03 0.02 1.69E-01 -0.007 0.001 2.48E-09 -0.005 0.002 2.14E-02 -0.019 0.004 1.60E-06 
rs2920293 PSCA g/c 0.00 0.02 8.57E-01 -0.006 0.001 5.04E-09 -0.007 0.002 9.17E-04 -0.015 0.004 9.94E-05 
rs4658101 CDC7/TGFBR
3 
a/g 0.06 0.03 4.46E-02 0.013 0.001 5.19E-23 0.007 0.003 1.13E-02 0.089 0.005 8.01E-77 
1:16953052
0 
F5/SELP i/r 0.02 0.03 4.22E-01 0.007 0.001 7.20E-07 0.005 0.003 5.44E-02 0.033 0.005 1.49E-12 
rs2239854 F5/SELP a/g 0.03 0.03 2.64E-01 0.006 0.001 8.37E-07 0.005 0.002 5.04E-02 0.030 0.004 7.60E-13 
rs9843102 ABI3BP a/g 0.00 0.03 9.84E-01 -0.006 0.002 2.18E-04 -0.002 0.003 5.88E-01 -0.036 0.005 1.35E-11 
8:88744441 DCAF4L2 d/r -0.01 0.02 6.98E-01 0.006 0.001 6.66E-07 0.006 0.002 4.53E-03 0.026 0.004 2.04E-11 
rs6468996 DCAF4L2 t/c 0.00 0.02 9.12E-01 0.005 0.001 2.52E-07 0.006 0.002 2.14E-03 0.025 0.004 5.16E-11 
rs61101201 ELP4/PAX6 g/t 0.02 0.03 5.51E-01 0.006 0.001 2.27E-06 0.005 0.002 4.51E-02 0.028 0.004 1.53E-10 
rs56385951 CARD10 a/g -0.06 0.04 9.08E-02 0.011 0.002 1.87E-11 0.008 0.003 8.83E-03 0.047 0.006 1.49E-16 
1:3046430 PRDM16 i/r -0.04 0.04 4.14E-01 0.007 0.002 5.35E-04 -0.002 0.004 7.15E-01 0.044 0.007 1.79E-09 
rs12028027 PRDM16 c/t -0.03 0.04 4.97E-01 0.007 0.002 2.15E-04 -0.001 0.004 8.58E-01 0.043 0.007 1.46E-09 
For these SNPs, the associations with the other traits are also included. Here the SNPs genome-wide significantly associated with vertical cup-disc ratio or with disc area that are 
Bonferroni significantly associated with the VCDR or disc area are shown in bold (p-value < 5.37 x 10-4; 0.05/93).Nearest gene, reference NCBI build37; β, effect size on effect size on 
the endophenotype (IOP, VCDR, cup area or disc area) based on allele A1; SE, standard error of the effect size; i, insertion; d, deletion; r, reference. 
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Table 3 Single nucleotide polymorphisms (SNPs) that are genome-wide significantly associated with optic nerve head parameters (cup area and disc area) 
   IOP VCDR Cup area Disc area 
SNP Nearest gene A1/A2 β SE P β SE P β SE P Β SE P 
1:227562773 CDC42BPA d/r -0.10 0.05 3.01E-02 0.003 0.002 2.37E-01 0.024 0.004 8.05E-09 -0.055 0.008 3.65E-13 
rs73102394 CDC42BPA t/c -0.09 0.05 4.34E-02 0.003 0.002 1.62E-01 0.022 0.004 4.16E-08 -0.053 0.007 5.01E-13 
rs11811982 CDC42BPA a/c -0.12 0.05 1.35E-02 0.004 0.002 5.54E-02 0.027 0.004 2.31E-10 -0.062 0.008 2.02E-15 
               
rs10021731 UGT8 c/t 0.01 0.02 8.23E-01 -0.002 0.001 5.56E-02 -0.002 0.002 2.68E-01 -0.020 0.004 7.48E-07 
rs12220165 CTNNA3* g/c 0.02 0.03 5.88E-01 -0.004 0.002 1.47E-02 -0.004 0.003 1.92E-01 -0.023 0.005 2.51E-05 
rs787541 U6, GADD45A c/g 0.07 0.03 7.08E-03 0.002 0.001 7.47E-02 0.002 0.002 4.82E-01 0.023 0.004 6.66E-08 
rs1367187 DIRC3 c/t -0.07 0.03 9.74E-03 0.002 0.001 2.46E-01 -0.002 0.003 4.87E-01 0.026 0.005 1.03E-08 
rs2443724 VGLL4 c/g 0.00 0.02 8.62E-01 -0.003 0.001 1.53E-02 0.000 0.002 9.15E-01 -0.022 0.004 4.72E-08 
rs1013830 CTNNA3 t/c 0.00 0.05 9.49E-01 -0.007 0.002 4.80E-03 -0.004 0.005 4.10E-01 -0.046 0.008 5.45E-08 
 
For these SNPs, the associations with the other traits are also included. SNPs that are Bonferroni significantly associated with other traits are shown in bold (p-value < 5.37 x 10-4; 
0.05/93). In the first rows, the SNPs genome-wide significantly associated with cup area are shown. Next, SNPs associated with only disc area, are shown. Nearest gene, reference 
NCBI build37; A1, reference allele; A2, other allele; β, effect size on the endophenotype (IOP, VCDR, cup area or disc area) based on allele A1; SE, standard error of the effect size; i, 
insertion; d, deletion; r, reference. *Genome-wide associated in the European-only meta-analysis.
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Table 4. Association with primary open-angle glaucoma in a meta-analysis of four independent glaucoma case-
control studies (ANZRAG, NEIGHBORHOOD, Singapore, and Southampton).  
 Nearest gene A1/A2 OR (95% CI) OR 
(R) 
P-value P-value 
(R) 
Direction I2 P-value of 
heterogeneity 
IOP SNPs 
 
 
 
 
 
 
 
 
 
rs10918274 TMCO1 t/c 1.39 (1.30-1.50) 1.39 2.75E-19 1.37E-09 ++++ 38.4 1.82E-01 
rs7635832 FNDC3B g/t 0.89 (0.83-0.95) 0.91 1.41E-03 3.65E-02 ---? 33.9 2.20E-01 
rs10281637 CAV1/CAV2 c/t 1.13 (1.07-1.20) 1.13 2.32E-05 2.32E-05 ++++ 0 4.89E-01 
rs2487048 ABCA1 a/g 1.26 (1.19-1.33) 1.26 2.65E-15 3.82E-03 ++++ 82.9 5.53E-04 
rs8176741 ABO a/g 1.07 (0.99-1.17) 1.04 7.36E-02 5.25E-01 -+-+ 58.5 6.51E-02 
rs7944735 Many genes 
(NUP160, PTPRJ) 
c/g 1.06 (1.01-1.13) 1.07 2.99E-02 2.99E-02 ++++ 0 8.99E-01 
11:120357425 ARHGEF12 d/r 1.16 (1.09-1.23) 1.19 1.52E-06 3.02E-02 ++++ 83.2 4.65E-04 
rs55796939 ADAMTS8 t/c 1.07 (0.94-1.24) 1.17 2.72E-01 4.46E-01 +?-- 78.6 9.35E-03 
rs9913911 GAS7 g/a 0.80 (0.76-0.84) 0.80 1.08E-17 1.08E-17 ---- 0 7.50E-01 
         
VCDR SNPs 
rs1925953 RPE65 t/a  1.07 (1.02-1.13) 1.10 4.21E-03 2.01E-02 ++++ 46.7 1.31E-01 
rs1192414 CDC7/TGFBR3 a/g 1.08 (1.02-1.16) 1.08 9.26E-03 9.26E-03 ++++ 0 7.27E-01 
rs10753787 F5 t/c 0.97 (0.93-1.03) 0.97 3.67E-01 3.67E-01 ---- 0 9.92E-01 
rs6804624 COL8A1 c/t 0.99 (0.94-1.05) 0.99 8.14E-01 8.14E-01 ---+ 0 8.42E-01 
rs72759609 PDZD2 c/t 0.90 (0.83-0.99) 0.91 3.20E-02 3.20E-02 ---- 0 9.53E-01 
rs114503346 DUSP1 t/c 1.00 (0.80-1.25) 1.00 9.99E-01 8.80E-01 +?-+ 42 1.78E-01 
rs4960295 RREB1 a/g 0.99 (0.95-1.05) 1.00 9.50E-01 9.09E-01 -+-+ 4.6 3.70E-01 
rs10274998 DGKB t/c 1.03 (0.98-1.10) 1.04 2.16E-01 2.16E-01 ++-+ 0 5.38E-01 
rs2157719 CDKN2B-AS1 c/t 0.69 (0.66-0.74) 0.69 1.29E-40 1.29E-40 ---- 0 5.67E-01 
rs1900005 ATOH7 a/c 1.01 (0.96-1.07) 1.01 6.98E-01 6.77E-01 +-++ 5.1 3.67E-01 
10:96008348 PLCE1 d/r 1.02 (0.97-1.09) 1.04 3.38E-01 3.15E-01 +-+? 35.3 2.13E-01 
rs1346 SSSCA1 t/a 0.90 (0.85-0.97) 0.91 2.41E-03 2.41E-03 ---- 0 9.04E-01 
rs4936099 ADAMTS8 c/a 0.94 (0.9-1.00) 0.94 5.75E-02 5.75E-02 ---- 0 9.63E-01 
rs324780 TMTC2 g/a 0.93 (0.89-0.99) 0.93 1.35E-02 1.35E-02 ---- 0 7.69E-01 
13:36629905 DCLK1 d/r 0.99 (0.94-1.05) 0.99 7.53E-01 8.00E-01 --+- 6.2 3.62E-01 
rs8015152 SIX6 t/c 1.21 (1.16-1.28) 1.19 3.90E-15 7.08E-05 ++++ 62.4 4.62E-02 
rs4299136 ASB7 c/g 1.03 (0.97-1.10) 1.03 3.55E-01 3.55E-01 ++-+ 0 8.29E-01 
16:51461915 SALL1 i/r 0.94 (0.89-1.00) 0.94 3.85E-02 3.85E-02 ---- 0 7.82E-01 
rs6107845 BMP2 a/g 0.89 (0.85-0.94) 0.91 1.02E-05 6.94E-03 ---- 43.1 1.53E-01 
rs5752773 CHEK2 g/c 0.92 (0.88-0.98) 0.92 4.63E-03 4.63E-03 ---- 0 9.12E-01 
rs2092172 CARD10 a/g 0.97 (0.92-1.04) 0.98 4.35E-01 4.35E-01 --+- 0 7.76E-01 
rs6764184 FLNB t/g 1.07 (1.02-1.13) 1.02 5.73E-03 7.66E-01 ++-+ 86.1 8.14E-05 
rs7717697 VCAN c/t 0.98 (0.93-1.04) 0.98 5.26E-01 5.26E-01 ---? 0 7.30E-01 
rs2920293 PSCA g/c 1.03 (0.98-1.09) 1.03 2.25E-01 2.25E-01  ++-? 0 3.79E-01 
rs1681739 ENO4 t/c 1.02 (0.97-1.08) 1.03 3.92E-01 3.99E-01 +--+ 49.2 1.16E-01 
rs7311936 FAM101A c/g 0.99 (0.95-1.04) 1.00 8.12E-01 8.59E-01 +--- 11 3.38E-01 
14:23388793 RBM23 r/d 1.03 (0.98-1.10) 1.03 1.83E-01 1.83E-01 +++? 0 4.61E-01 
 
Cup area SNPs 
rs2252865 RERE t/c 1.11 (1.06-1.18) 1.11 5.76E-05 2.87E-02 ++-+ 59.3 6.10E-02 
rs4846112 DHRS3 a/g 0.95 (0.91-1.01) 0.96 1.18E-01 1.18E-01 ---- 0 5.53E-01 
1:227562773 CDC42BPA d/r 0.87 (0.79-0.97) 0.90 1.14E-02 2.11E-01 --+? 48.6 1.43E-01 
rs13016883 TRIB2 c/g 1.08 (1.03-1.14) 1.08 4.25E-03 4.25E-03 +++? 0 8.63E-01 
rs35084382 DUSP1 c/t 1.04 (0.85-1.29) 1.05 6.72E-01 6.72E-01  +?-+ 0 3.91E-01 
rs117598310 CRISPLD1 t/g 1.08 (1.00-1.19) 1.09 5.39E-02 5.39E-02 +++ 0 8.01E-01 
rs1360589 CDKN2B-AS1 c/t 0.69 (0.66-0.73) 0.69 1.90E-42 1.90E-42 ---- 0 6.47E-01 
rs10998036 ATOH7 c/g 1.01 (0.96-1.08) 1.02 5.42E-01 5.72E-01 +--- 26 2.55E-01 
10:96008348 PLCE1 d/r 1.02 (0.97-1.09) 1.04 3.38E-01 3.15E-01 +-+? 35.3 2.13E-01 
rs1346 SSSCA1 t/a  0.90 (0.85-0.97) 0.91 2.41E-03 2.41E-03 ---- 0 9.04E-01 
rs482507 TMTC2 c/t 0.94 (0.89-0.99) 0.94 2.03E-02 2.03E-02 ---- 0 7.46E-01 
rs11613189 FAM101A t/c 0.99 (0.95-1.05) 0.99 8.25E-01 7.77E-01 ++-- 18.5 2.98E-01 
rs7323428 DCLK1 t/g 0.99 (0.94-1.05) 1.00 7.83E-01 8.87E-01 +-+- 13.6 3.25E-01 
rs2251069 DDHD1 c/t 0.95 (0.91-1.00) 0.96 7.62E-02 7.62E-02  --+- 0 4.08E-01 
rs4436712 SIX6 t/g 1.24 (1.19-1.31) 1.23 
 
 
 
5.77E-18 1.52E-07 ++++ 48.8 1.19E-01 
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 Nearest gene A1/A2 OR (95% CI) OR 
(R) 
P-value P-value 
(R) 
Direction I2 P-value of 
heterogeneity 
 
Cup area SNPs 
rs6598351 FAM169B t/c 0.99 (0.93-1.06) 0.99 8.06E-01 8.06E-01 -+-- 0 7.11E-01 
rs11646917 SALL1 t/3g 0.98 (0.93-1.04) 0.98 5.49E-01 5.49E-01 --++ 0 5.97E-01 
rs11867840 BCAS3 g/a 1.06 (1.01-1.13) 1.06 1.83E-02 2.12E-02 ++++ 8.3 3.51E-01 
rs6054375 BMP2 t/g 0.89 (0.85-0.94) 0.91 8.52E-06 9.93E-03 ---- 47.1 1.29E-01 
rs738722 CHEK2 t/c 0.93 (0.89-0.99) 0.93 1.26E-02 1.26E-02 ---- 0 9.05E-01 
rs3791679 EFEMP1/PNPT1 a/g 0.96 (0.92-1.02) 0.96 2.23E-01 2.23E-01 ---- 0 5.51E-01 
rs12494328 FLNB a/g 1.13 (1.07-1.20) 1.13 1.28E-05 5.89E-04 ++-+ 26.9 2.50E-01 
rs6804624 COL8A1 c/t 0.99 (0.94-1.05) 0.99 8.14E-01 8.14E-01 ---+ 0 8.42E-01 
6:36592986 CDKN1A d/r 1.14 (1.09-1.21) 1.15 7.74E-07 1.04E-04 ++++ 36.6 1.93E-01 
rs2684249 HSF2 c/t 0.92 (0.88-0.97) 0.94 1.08E-03 1.66E-01 ---+ 63.3 4.25E-02 
rs8176672 ABO t/c 1.00 (0.91-1.11) 1.00 9.49E-01 9.49E-01 -+-? 0 3.69E-01 
rs4936099 ADAMTS8 c/a 0.94 (0.90-1.00) 0.94 5.75E-02 5.75E-02 ---- 0 9.63E-01 
rs34222435 ASB7 t/c 1.03 (0.97-1.10) 1.03 3.66E-01 3.66E-01 ++-+ 0 8.74E-01 
rs1074407 TRIOBP t/a 1.04 (1.00-1.10) 1.04 4.92E-02 8.66E-02 ++++ 32.9 2.15E-01 
          
Disc area SNPs 
rs4658101 CDC7/TGFBR3 a/g 1.08 (1.02-1.16) 1.08 7.81E-03 7.81E-03 ++++ 0 7.22E-01 
1:169530520 F5/SELP i/r 1.01 (0.96-1.08) 1.02 5.40E-01 5.40E-01 ++-? 0 7.14E-01 
rs11811982 CDC42BPA a/c 0.87 (0.80-0.97) 0.90 1.19E-02 8.28E-02 --++ 20.5 2.87E-01 
rs9843102 ABI3BP a/g 0.92 (0.86-0.98) 0.92 1.37E-02 1.37E-02 ---- 0 6.24E-01 
rs10021731 UGT8 c/t 1.01 (0.96-1.06) 1.01 6.82E-01 6.82E-01  --++ 0 6.50E-01 
8:88744441 DCAF4L2 d/r 1.03 (0.99-1.09) 1.04 0.1225 1.39E-01 ++-+ 4.9 3.68E-01 
rs12220165 CTNNA3 g/c 1.08 (1.01-1.16) 1.09 1.14E-02 1.14E-02 ++++ 0 9.04E-01 
rs7916410 ATOH7 t/c 1.00 (0.96-1.06) 1.00 7.63E-01 7.45E-01 +-++ 3.9 3.73E-01 
rs61101201 ELP4/PAX6 g/t 1.00 (0.94-1.06) 1.00 9.77E-01 9.77E-01  -+-? 0 9.63E-01 
rs442376 TMTC2 c/t 1.04 (0.99-1.10) 1.05 7.94E-02 7.94E-02  -+++ 0 6.82E-01 
rs1345467 SALL1 g/a  1.07 (1.01-1.14) 1.07 1.86E-02 1.86E-02 ++++ 0 8.73E-01 
rs5762752 CHEK2 c/g 0.92 (0.88-0.98) 0.92 4.90E-03 4.90E-03 ---- 0 8.29E-01 
rs56385951 CARD10 a/g 0.99 (0.92-1.07) 1.00 9.15E-01 9.15E-01 +-+- 0 9.88E-01 
1:3046430 PRDM16 i/r 0.97 (0.87-1.10) 0.98 7.13E-01 8.72E-01 +--? 63.9 6.28E-02 
rs787541 U6, GADD45A c/g 0.98 (0.94-1.04) 0.98 6.10E-01 9.06E-01 --++ 50.7 1.08E-01 
rs1367187 DIRC3 c/t 0.95 (0.90-1.01) 0.96 1.11E-01 4.12E-01  +-+- 46.1 1.35E-01 
rs2443724 VGLL4 c/g 0.91 (0.87-0.97) 0.91 1.04E-03 2.61E-02 --+- 38 1.84E-01 
rs11129176 RARB a/g 0.99 (0.94-1.05) 1.00 8.85E-01 9.93E-01 +--- 40.4 1.69E-01 
rs1997404 COL8A1 g/t 1.00 (0.95-1.06) 1.00 9.60E-01 9.60E-01  -+++ 0 6.18E-01 
rs34935520 SIX6 g/a 1.26 (1.20-1.33) 1.26 2.82E-20 6.73E-14 ++++ 21.5 2.81E-01 
rs60779155 ASB7 a/g 1.02 (0.96-1.10) 1.03 4.52E-01 4.52E-01 +--+ 0 5.02E-01 
Results are shown for the most significantly associated single nucleotide polymorphisms from the endophenotype analyses. 
Nearest gene, reference NCBI build37; A1, reference allele; A2, other allele; OR, estimated odds ratio for allele A1; 95% CI, 
confidence interval; OR (R), estimated odds ratio for allele A1 in random effect meta-analysis; P-value (R), p-value in 
random effect meta-analysis; I2 statistic measuring heterogeneity on a scale of 0% to 100%; i, insertion; d, deletion; r, 
reference. 
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Abbreviations 
Abbreviation Explanation 
A1 Reference allele  
A2 Other allele 
Chr Chromosome 
CI  confidence interval 
d Deletion  
FDR False Discovery Rate 
GWAS Genome-wide association studies  
h2 Heritability 
i Insertion  
I2  Statistic measuring heterogeneity on a scale of 0% to 100% 
IGGC International Glaucoma Genetics Consortium 
IOP Intraocular pressure  
LCA2 Leber Congenital Amaurosis type 2  
LD Linkage disequilibrium 
MAF Minor allele frequency  
OR Estimated odds ratio for allele A1  
OR (R) Estimated odds ratio for allele A1 in random effect meta-analysis 
POAG Primary open-angle glaucoma 
r  Reference 
RP Retinitis Pigmentosa 
SE  Standard error 
SNPs Single nucleotide polymorphisms  
VCDR Vertical cup-disc ratio  
β  Effect size  
 
